PHASE-II TRIALS OF CISPLATIN AND PIPERAZINEDIONE AS SINGLE AGENTS IN THE TREATMENT OF ADVANCED OR RECURRENT NON-SQUAMOUS CELL-CARCINOMA OF THE CERVIX - A GYNECOLOGIC ONCOLOGY GROUP-STUDY

被引：0
|
作者：
THIGPEN, JT
BLESSING, JA
FOWLER, WC
HATCH, K
机构：
[1] UNIV MISSISSIPPI,MED CTR,SCH MED,DEPT MED,DIV ONCOL,JACKSON,MS 39216
[2] UNIV MISSISSIPPI,MED CTR,SCH MED,DEPT OBSTET & GYNECOL,JACKSON,MS 39216
[3] NEW YORK STATE DEPT HLTH,ROSWELL PK MEM INST,GYNECOL ONCOL GRP,BUFFALO,NY 14263
[4] UNIV N CAROLINA,SCH MED,DEPT OBSTET & GYNECOL,DIV GYNECOL ONCOL,CHAPEL HILL,NC 27514
[5] UNIV ALABAMA,DIV GYNECOL ONCOL,BIRMINGHAM,AL 35294
来源：
CANCER TREATMENT REPORTS | 1986年 / 70卷 / 09期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：1097 / 1100
页数：4
相关论文
共 50 条
  • [11] PHASE-II STUDY OF MAYTANSINE IN THE TREATMENT OF ADVANCED OR RECURRENT SQUAMOUS-CELL CARCINOMA OF THE CERVIX - A GYNECOLOGIC-ONCOLOGY-GROUP STUDY
    THIGPEN, JT
    EHRLICH, CE
    CONROY, J
    BLESSING, JA
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 1983, 6 (04): : 427 - 430
  • [12] PHASE-II TRIAL OF PIPERAZINEDIONE IN THE TREATMENT OF ADVANCED OR RECURRENT ENDOMETRIAL CARCINOMA - A GYNECOLOGIC-ONCOLOGY-GROUP STUDY
    THIGPEN, JT
    BLESSING, JA
    HOMESLEY, HD
    PETTY, W
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 1986, 9 (01): : 21 - 23
  • [13] PHASE-II CLINICAL-TRIAL OF DIAZIQUONE IN THE TREATMENT OF PATIENTS WITH RECURRENT SQUAMOUS-CELL CARCINOMA OF THE CERVIX - A GYNECOLOGIC ONCOLOGY GROUP-STUDY
    SLAYTON, RE
    BLESSING, JA
    STEHMAN, FB
    MALFETANO, J
    CANCER TREATMENT REPORTS, 1986, 70 (09): : 1127 - 1128
  • [14] PHASE-II TRIAL OF CISPLATIN IN ADVANCED OR RECURRENT CANCER OF THE VAGINA - A GYNECOLOGIC ONCOLOGY GROUP-STUDY
    THIGPEN, JT
    BLESSING, JA
    HOMESLEY, HD
    BEREK, JS
    CREASMAN, WT
    GYNECOLOGIC ONCOLOGY, 1986, 23 (01) : 101 - 104
  • [15] Cisplatin and pentoxifylline in advanced or recurrent squamous cell carcinoma of the cervix: A phase II trial of the gynecologic oncology group
    Mannel, RS
    Blessing, JA
    Boike, G
    GYNECOLOGIC ONCOLOGY, 2000, 79 (01) : 64 - 66
  • [16] PHASE-II STUDY OF VINBLASTINE IN PREVIOUSLY TREATED SQUAMOUS CARCINOMA OF THE CERVIX - A GYNECOLOGIC ONCOLOGY GROUP-STUDY
    SUTTON, GP
    BLESSING, JA
    BARNES, W
    BALL, H
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 1990, 13 (06): : 470 - 471
  • [17] PHASE-II TRIAL OF ADRIAMYCIN IN THE TREATMENT OF ADVANCED OR RECURRENT ENDOMETRIAL CARCINOMA - GYNECOLOGIC ONCOLOGY GROUP-STUDY
    THIGPEN, JT
    BUCHSBAUM, HJ
    MANGAN, C
    BLESSING, JA
    CANCER TREATMENT REPORTS, 1979, 63 (01): : 21 - 27
  • [18] A PHASE-II TRIAL OF GALLIUM NITRATE (NSC-15200) IN ADVANCED OR RECURRENT SQUAMOUS-CELL CARCINOMA OF THE CERVIX - A GYNECOLOGIC ONCOLOGY GROUP-STUDY
    MALFETANO, JH
    BLESSING, JA
    HOMESLEY, HD
    HANJANI, P
    INVESTIGATIONAL NEW DRUGS, 1991, 9 (01) : 109 - 111
  • [19] Prolonged oral etoposide in recurrent or advanced non-squamous cell carcinoma of the cervix: a Gynecologic Oncology Group study
    Rose, PG
    Blessing, JA
    Buller, RE
    Mannel, RS
    Webster, KD
    GYNECOLOGIC ONCOLOGY, 2003, 89 (02) : 267 - 270
  • [20] PHASE-II STUDY OF ESORUBICIN (4'-DEOXYDOXORUBICIN) IN ADVANCED OR METASTATIC SQUAMOUS CARCINOMA OF THE UTERINE CERVIX - A GYNECOLOGIC ONCOLOGY GROUP-STUDY
    MCGUIRE, WP
    BLESSING, JA
    YORDAN, E
    BEECHAM, J
    INVESTIGATIONAL NEW DRUGS, 1989, 7 (2-3) : 235 - 238
12345